SFERA® Calcium Hydroxylapatite (CaHA) Biostimulator | Advanced Neocollagenesis Filler

Short Description

A next-generation injectable dermal biostimulator and structural contouring filler formulated with micro-spherical Calcium Hydroxylapatite (CaHA ~30%) homogeneously suspended in an aqueous Carboxymethylcellulose (CMC ~70%) gel carrier. Designed to deliver immediate mechanical revolumization followed by long-term regenerative biostimulation, SFERA® Calcium triggers robust de novo Type I and Type III neocollagenesis, elastogenesis, and angiogenesis. Delivered undiluted for deep structural lifting along the supraperiosteal plane or hyperdiluted for widespread subdermal skin redensification, it tightens skin laxity, restores jawline definition, and improves tissue architecture across the face, neck, décolleté, and body.

Detailed Description & Dual-Stage Mechanism of Action

SFERA® Calcium utilizes synthetic, biocompatible Calcium Hydroxylapatite microspheres identical in chemical composition to the mineral constituent of human bone and teeth. The microspheres are engineered with an ultra-smooth, spherical morphology ranging between 25 and 45 microns ($\mu$m) in diameter. This precise calibration prevents phagocytosis by small macrophages while eliminating sharp edges, minimizing foreign-body granulomatous inflammation.

Injection of SFERA® CaHA Matrix (30% CaHA Microspheres + 70% CMC Gel)
  │
  ├── Stage 1: Immediate Volume (Months 0–3)
  │     └── CMC Gel provides physical scaffolding, immediate lifting, and wrinkle correction
  │
  ├── Stage 2: Biological Transformation (Months 2–4)
  │     └── Macrophages metabolize the soluble CMC carrier via endogenous enzymatic pathways
  │
  └── Stage 3: Sustained Neocollagenesis & Remodeling (Months 4–18+)
        └── Fibroblasts anchor to CaHA spheres ──► Type I/III Collagen + Elastin + Angiogenesis

1. Stage 1: Immediate Mechanical Scaffolding (Months 0 to 3):

   • Upon injection, the highly cohesive carboxymethylcellulose (CMC) hydrogel provides instantaneous tissue projection, physical volume correction, and smoothing of structural deficits.

   • The CaHA microspheres remain immobilized within the gel matrix, preventing particle migration.

2. Stage 2: Carrier Gel Resorption & Cellular Infiltration (Months 2 to 4):

   • The surrounding tissue gradually breaks down the aqueous CMC gel carrier through standard macrophage-mediated metabolic pathways.

   • Concurrently, endogenous tissue fluids bathe the CaHA microspheres, and host fibroblasts migrate into the porous interstitial lattice created between the spheres.

3. Stage 3: Endogenous Neocollagenesis & Structural Remodeling (Months 4 to 18+):

   • Physical interaction between the smooth CaHA spheres and fibroblast cell-surface integrins activates mechanotransduction cascades.

   • Fibroblasts deposit extensive, organized networks of Type I and Type III collagen, fibrillar elastin, and proteoglycans.

   • Over 12 to 18 months, the CaHA particles undergo slow physiological dissolution into calcium ($Ca^{2+}$) and phosphate ($PO_4^{3-}$) ions, leaving behind an integrated autologous scaffold of dense, living connective tissue.

Treatment Areas & Clinical Indications

• Structural Contouring & Revolumization (Undiluted / Deep Planes):

  • Mandibular angle sharpening and jawline border definition

  • Chin projection and mentolabial sulcus filling

  • Deep malar and zygomatic bone enhancement

  • Deep nasolabial folds and marionette lines

• Skin Tightening & Tissue Biostimulation (Hyperdiluted Planes):

  • Midface and lateral cheek elastosis and static accordion laugh lines

  • Cervical horizontal rings and platysmal skin crepeyness

  • Cleavage sleep wrinkles and solar poikiloderma on the décolleté

  • Dorsal hand rejuvenation (soft-tissue atrophy and visible veins/tendons)

• Body Skin Redensification:

  • Post-weight loss or postpartum abdominal skin laxity

  • Upper arm flaccidity (brachial crepeyness)

  • Inner thigh skin laxity and suprapatellar knee folds

  • Buttock skin tightening and cellulite contour smoothing

Key Clinical Advantages

• Predictable, Sustained Longevity: Delivers sustained clinical results lasting 12 to 18+ months—significantly longer than non-cross-linked or standard linear hyaluronic acid boosters.

• Controlled Dual-Action Kinetics: Provides immediate visual volume correction from the carrier gel that transitions directly into long-term neocollagenesis as the gel resorbs.

• Biocompatible & 100% Biodegradable: CaHA breaks down into natural calcium and phosphate ions excreted via normal renal and pulmonary pathways, requiring no pre-treatment allergy testing.

• Smooth Spherical Geometry (25–45 $\mu$m): High sphericity minimizes tissue friction, facilitates easy extrusion through fine microcannulas (25G or 27G), and prevents irregular cellular aggregation.

• Hyperdilution Adaptability: Serves both as a volumizing structural implant and as a high-coverage regenerative wash for tissue tightening across the face and body.

Clinical Administration & Delivery Protocols

Comparative Benchmark: SFERA CaHA vs. Radiesse vs. Facetem vs. Sculptra

Professional Medical Advisory: SFERA® Calcium is a specialized Class III medical device restricted strictly to board-certified dermatologists, plastic surgeons, and credentialed aesthetic physicians trained in advanced dermal fill and vectoring techniques.

• Absolute Contraindicated Anatomical Zones: Never inject into the glabellar complex, nasal dorsum/tip, or the red vermilion of the lips. Injection into the dynamic perioral or periorbital sphincter musculature carries a high risk of visible nodule formation.

• Intravascular Risk: Accidental intravascular injection can lead to cutaneous necrosis, embolization, or vascular occlusion. Aspiration for a minimum of 5 seconds prior to high-pressure bolus injections is mandatory. The use of blunt-tip cannulas (25G or larger) is strongly advised for subcutaneous fanning.

• Reconstitution Protocol: When performing hyperdilution, connect the SFERA syringe to the diluent syringe using a sterile female-to-female luer-lock connector and push back and forth for a minimum of 20 to 30 complete passes to guarantee uniform microsphere suspension.